The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Insulin resistance and Alzheimer's disease
Open accessAbstract
Emerging data demonstrate pivotal roles for brain insulin resistance and insulin deficiency as mediators of cognitive impairment and neurodegeneration, particularly Alzheimer's disease (AD). Insulin and insulin-like growth factors (IGFs) regulate neuronal survival, energy metabolism, and plasticity, which are required for learning and memory. Hence, endogenous brain-specific impairments in insulin and IGF signaling account for the majority of AD-associated abnormalities. However, a second major mechanism of cognitive impairment has been linked to obesity and Type 2 diabetes (T2DM). Human and experimental animal studies revealed that neurodegeneration associated with peripheral insulin resistance is likely effectuated via a liver-brain axis whereby toxic lipids, including ceramides, cross the blood brain barrier and cause brain insulin resistance, oxidative stress, neuro-inflammation, and cell death. In essence, there are dual mechanisms of brain insulin resistance leading to AD-type neurodegeneration: one mediated by endogenous, CNS factors; and the other, peripheral insulin resistance with excess cytotoxic ceramide production.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alterations in the insulin signaling pathway have also been suggested as potential contributors to cognitive dysfunction because of the pivotal role of this hormone in modulating brain structure and function.[12][13][14]”
In the citing paper
“It is becoming clear that the obesity-induced toxic internal environment does not spare the brain ([24](#B24), [46](#B46), [48](#B48), [52](#B52), [59](#B59), [95](#B95), [121](#B121), [127](#B127), [177](#B177), [182](#B182), [198](#B198)).”
From Food reward, hyperphagia, and obesity (2011) · cites this paper as [46]
In the citing paper
“Recent evidence suggests that insulin resistance, a hallmark of diabetes, develops in Alzheimer’s brains (, 2000; Craft et al., 1999; de la Monte, 2009; Moroz et al., 2008; Pedersen and Flynn, 2004; Razay and Wilcock, 1994; Watson and Craft, 2003).”
From The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease (2011) · cites this paper as de la Monte, 2009
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The mechanism of alloxan and streptozotocin action in B cells of the rat pancreas
Szkudelski, T. (2001) · Physiological Research · doi:10.33549/physiolres.930111 · Cited by 2,881
Regulation of neuronal survival by the serine-threonine protein kinase Akt
Dudek, H., Datta, S. R., Franke, T. F., Birnbaum, M. J., Yao, R., Cooper, G. M., Segal, R. A., Kaplan, D. R., & Greenberg, M. E. (1997) · Science · doi:10.1126/science.275.5300.661 · Cited by 2,436
Human insulin receptor and its relationship to the tyrosine kinase family of oncogenes
Ullrich, A., Bell, J. R., Chen, E. Y., Herrera, R., Petruzzelli, L., Dull, T. J., Gray, A., Coussens, L. M., Liao, Y.-C., Tsubokawa, M., et al. (1985) · Nature · doi:10.1038/313756a0 · Cited by 2,251
GSK-3: tricks of the trade for a multi-tasking kinase
Doble, B. W., & Woodgett, J. R. (2003) · Journal of Cell Science · doi:10.1242/jcs.00384 · Cited by 2,084
Steen, E., Terry, B. M., J. Rivera, E., Cannon, J. L., Neely, T. R., Tavares, R., Xu, X. J., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer's Disease · doi:10.3233/jad-2005-7107 · Cited by 1,703
Alzheimer’s disease is type 3 diabetes—Evidence reviewed
de la Monte, S. M., & Wands, J. R. (2008) · Journal of Diabetes Science and Technology · doi:10.1177/193229680800200619 · Cited by 1,158
Ceramides in insulin resistance and lipotoxicity
Summers, S. A. (2005) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 866
Intranasal insulin improves cognition and modulates β-amyloid in early AD
Reger, M. A., Watson, G. S., Green, P. S., Wilkinson, C. W., Baker, L. D., Cholerton, B., Fishel, M. A., Plymate, S. R., Breitner, J. C. S., DeGroodt, W., et al. (2008) · Neurology · doi:10.1212/01.wnl.0000265401.62434.36 · Cited by 830
Rivera, E. J., Goldin, A., Fulmer, N., Tavares, R., Wands, J. R., & de la Monte, S. M. (2005) · Journal of Alzheimer s Disease · doi:10.3233/jad-2005-8304 · Cited by 723 · cited 15×
“In addition, inhibition of insulin/IGF-1 signaling blocks the Wnt pathway (24), which negatively regulates GSK-3β via a PI3K/Akt-independent mechanism.”
BackgroundInfluentialHolland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 604
Flagged first, then by citations
Cited by
Sorted by citations
Items 201–300 of 392
Diabetic encephalopathy: the role of oxidative stress and inflammation in type 2 diabetes
Reis, F., Soares, Nunes, & Pereira, F. C. (2012) · International Journal of Interferon Cytokine and Mediator Research · doi:10.2147/ijicmr.s29322 · Cited by 26
Exogenous Ketone Supplements Improved Motor Performance in Preclinical Rodent Models
Ari, C., Murdun, C., Goldhagen, C. R., Koutnik, A. P., Bharwani, S., Diamond, D. M., Kindy, M. S., D’Agostino, D. P., & Kovács, Z. (2020) · Nutrients · doi:10.3390/nu12082459 · Cited by 23
Cognitive Dysfunction in Older Adults with Type 2 Diabetes
Sinclair, A. J., & Abdelhafiz, A. H. (2020) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2020.04.002 · Cited by 23
Differential regulation of insulin signalling by monomeric and oligomeric amyloid beta-peptide
Molina-Fernández, R., Picón-Pagès, P., Barranco-Almohalla, A., Crepin, G., Herrera-Fernández, V., García-Elías, A., Fanlo-Ucar, H., Fernàndez‐Busquets, X., García‐Ojalvo, J., Oliva, B., et al. (2022) · Brain Communications · doi:10.1093/braincomms/fcac243 · Cited by 23
Diabesity and Brain Energy Metabolism: The Case of Alzheimer’s Disease
Cardoso, S., Seiça, R. M. F., & Moreira, P. I. (2017) · Advances in neurobiology · doi:10.1007/978-3-319-63260-5_5 · Cited by 24
Ottanà, R., Paoli, P., Lori, G., Adornato, I., Previti, S., Naß, A., Wolber, G., & Maccari, R. (2019) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2019.103211 · Cited by 22
Kwon, B., Gamache, T., Lee, H., & Querfurth, H. W. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2015.05.012 · Cited by 23
Redox imbalance and metabolic defects in the context of Alzheimer disease
Domenico, F. D., Lanzillotta, C., & Marzia Perluigi, A. (2024) · FEBS Letters · doi:10.1002/1873-3468.14840 · Cited by 22
Mill, J., & Li, L. (2022) · Phenomics · doi:10.1007/s43657-021-00036-9 · Cited by 21
Sachdeva, A. K., Dharavath, R. N., & Chopra, K. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.06.966 · Cited by 21
Crunfli, F., Mazucanti, C. H., de Moraes, R. C. M., Costa, A. P., Rodrigues, A. C., Scavone, C., & Torrão, A. D. S. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180284 · Cited by 21
Ullah, R., Ali, G., Baseer, A., Khan, S. I., Akram, M., Khan, S., Ahmad, N., Farooq, U., Nawaz, N. K., Shaheen, S., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.108970 · Cited by 20
Chocolate and Cocoa-Derived Biomolecules for Brain Cognition during Ageing
Zeli, C., Lombardo, M., Storz, M. A., Ottaviani, M., & Rizzo, G. (2022) · Antioxidants · doi:10.3390/antiox11071353 · Cited by 22
Can Allostery Be a Key Strategy for Targeting PTP1B in Drug Discovery? A Lesson from Trodusquemine
Maccari, R., & Ottanà, R. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119621 · Cited by 21
Girard, H., Potvin, O., Nugent, S., Dallaire‐Théroux, C., Cunnane, S. C., & Duchesne, S. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.11.013 · Cited by 20
Can the Treatment of Vascular Risk Factors Slow Cognitive Decline in Alzheimer's Disease Patients?
Richard, F., & Pasquier, F. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121012 · Cited by 22
Distinct and joint effects of low and high levels of Aβ and tau deposition on cortical thickness
Hojjati, S. H., Butler, T., Chiang, G. C.-Y., Habeck, C. G., RoyChoudhury, A., Feiz, F., Shteingart, J., Nayak, S., Ozoria, S., Guerrero, A. F., et al. (2023) · NeuroImage Clinical · doi:10.1016/j.nicl.2023.103409 · Cited by 17
Arunsak, B., Pratchayasakul, W., Amput, P., Chattipakorn, K., Tosukhowong, T., Kerdphoo, S., Jaiwongkum, T., Thonusin, C., Palee, S., Chattipakorn, N., et al. (2020) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2020.108470 · Cited by 19
Robbins, J., Busquets, O., Tong, M., & de la Monte, S. M. (2020) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-200238 · Cited by 19
Hepatic Encephalopathy and Melatonin
Arjunan, A., Sah, D. K., Jung, Y. D., & Song, J. (2022) · Antioxidants · doi:10.3390/antiox11050837 · Cited by 20
Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease
Khan, F. Z., Mostaid, M. S., & Apu, M. N. H. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e09874 · Cited by 20
Bagheri‐Mohammadi, S., Askari, S., Alani, B., Moosavi, M., & Ghasemi, R. (2022) · Journal of Molecular Neuroscience · doi:10.1007/s12031-022-02075-x · Cited by 19
Zimbone, S., Rosa, M. C. D., Chiechio, S., & Giuffrida, M. L. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241512456 · Cited by 18
Tong, M., Leão, R. A. C., Vimbela, G. V., Yalcin, E. B., Kay, J., Krotow, A., & de la Monte, S. M. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.04.010 · Cited by 17
Insulin resistance is associated with verbal memory impairment in bipolar disorders
Salvi, V., Salvo, G. D., Korčáková, J., Torriero, S., Aragno, E., Kolenič, M., Ungrmanová, M., Maina, G., Mencacci, C., & Hájek, T. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.01.145 · Cited by 17
Alzheimer's disease and type 2 diabetes: Two diseases, one common link?
Bartl, J., Monoranu, C., Schilling, A.-K., Kolter, J. F., Riederer, P., & Grünblatt, E. (2012) · The World Journal of Biological Psychiatry · doi:10.3109/15622975.2011.650204 · Cited by 17
Insulin Resistance and Alzheimer’s Disease
Min, S., Joon, H. S., & Mook‐Jung, I. (2011) · InTech eBooks · doi:10.5772/23409 · Cited by 17
Diabetes of the Brain: Computational Approaches and Interventional Strategies
Narasimhan, K., Meenakumari, G., Gauthaman, K., Kamal, M. A., Abuzenadeh, A. M., Al-Qahtani, M., & Kanagasabai, R. (2014) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/18715273113126660156 · Cited by 16
Zhang, Y., Chen, D., Zhang, M., Bian, J., Qian, S., & Kou, X. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.01.007 · Cited by 16
Lin, H., Chung, C., Chen, L., Wang, J., Chen, C., Huang, K., Tsai, M.-H., Chien, W., & Lin, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-33674-2 · Cited by 17
Ayromlou, H., Hosseini, S., Khalili, M., Ayromlou, S., Khamudchiyan, S., Farajdokht, F., Hassannezhad, S., & Moghadam, S. A. (2023) · Journal of Neuroendocrinology · doi:10.1111/jne.13288 · Cited by 15
Chan, E. S., Chen, C., Soong, T. W., & Wong, B. (2018) · NeuroMolecular Medicine · doi:10.1007/s12017-018-8480-3 · Cited by 14
Versace, S., Pellitteri, G., Sperotto, R., Tartaglia, S., Porto, A. D., Catena, C., Gigli, G. L., Cavarape, A., & Valente, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241310615 · Cited by 17
Prediabetes and alzheimer's disease
Rapaka, D., Bitra, V. R., & Akula, A. (2015) · Indian Journal of Pharmaceutical Sciences · doi:10.4103/0250-474x.169026 · Cited by 15
Craig, A., Parvez, F., & Issberner, J. (2019) · Behavioural Brain Research · doi:10.1016/j.bbr.2019.112015 · Cited by 15
Should We Target Insulin Resistance to Prevent Dementia Due to Alzheimer Disease?
Luchsinger, J. A., Small, S. A., & Biessels, G. J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2010.339 · Cited by 15
Ayan, E. B., & DeMi̇rci̇, H. (2022) · Current Diabetes Reviews · doi:10.2174/1573399819666220610150342 · Cited by 14
Ma, L., Wei, Q., Deng, H., Zhang, Q., Li, G., Tang, N., Xie, J., & Chen, Y. (2013) · Journal of Neuroendocrinology · doi:10.1111/jne.12040 · Cited by 14
Brain energy metabolism parameters in an animal model of diabetes
Ceretta, L. B., Réus, G. Z., Rezin, G. T., Scaini, G., STRECK, E. L., & Quevedo, J. (2010) · Metabolic Brain Disease · doi:10.1007/s11011-010-9220-z · Cited by 14
Neuroenergetics of traumatic brain injury
Karelina, K., & Weil, Z. M. (2015) · Concussion · doi:10.2217/cnc.15.9 · Cited by 14
Zhang, D., Jiang, S., & Meng, H. (2015) · International Journal of Endocrinology · doi:10.1155/2015/626019 · Cited by 14
Yanagita, T., Nemoto, T., Satoh, S., Yoshikawa, N., Maruta, T., Shiraishi, S., Sugita, C., & Murakami, M. (2013) · InTech eBooks · doi:10.5772/54389 · Cited by 14
Fernando, H. J., Cohen, R. A., Gullett, J. M., Friedman, J. E., Ayzengart, A., Porges, E. C., Woods, A. J., Gunstad, J., Ochoa, C. M., Cusi, K. J., et al. (2019) · Obesity · doi:10.1002/oby.22508 · Cited by 13
Rashtiani, S., Goudarzi, I., Jafari, A., & Rohampour, K. (2021) · Neuroscience Letters · doi:10.1016/j.neulet.2021.135721 · Cited by 13
Kumar, A., Doan, V. M., Kunkli, B., & Csősz, É. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.633050 · Cited by 12
Shateri, Z., Kooshki, A., Hormoznejad, R., Hosseini, S. A., Mousavi, R., & Foroumandi, E. (2023) · Phytotherapy Research · doi:10.1002/ptr.7896 · Cited by 13
Wei, C., Li, X., Yu, J. Z., Zhang, Y., & Yuan, Q. (2024) · Journal of Cellular Physiology · doi:10.1002/jcp.31287 · Cited by 13
Neuroinflammation is not a Prerequisite for Diabetes-induced Tau Phosphorylation
van der Harg, J. M., Eggels, L., Ruigrok, S. R., Hoozemans, J. J. M., la Fleur, S. E., & Scheper, W. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00432 · Cited by 12
The Strategies for Treating “Alzheimer’s Disease”: Insulin Signaling May Be a Feasible Target
You, G., Yao, J., Liu, Q., & Li, N. (2022) · Current Issues in Molecular Biology · doi:10.3390/cimb44120421 · Cited by 12
Task-related fMRI BOLD response to hyperinsulinemia in healthy older adults
Williams, V. J., Trombetta, B. A., Jafri, R. Z., Koenig, A. M., Wennick, C. D., Carlyle, B. C., Ekhlaspour, L., Ahima, R. S., Russell, S. J., Salat, D. H., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.129700 · Cited by 12
Mei, Y., Li, Y., Cheng, Y., & Gao, L. (2023) · Experimental Neurology · doi:10.1016/j.expneurol.2023.114377 · Cited by 11
Dementia in diabetes mellitus and atherosclerosis: Two interrelated systemic diseases
Moghaddam, P. M., Ghobadian, R., & Khaleghzadeh‐Ahangar, H. (2022) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2022.01.018 · Cited by 10
Role of acid sphingomyelinase in the regulation of mast cell function
Yang, W., Schmid, E., Nurbaeva, M. K., Szteyn, K., Leibrock, C. B., Yan, J., Schaller, M., Gulbins, E., Shumilina, E., & Lang, F. J. W. (2013) · Clinical & Experimental Allergy · doi:10.1111/cea.12229 · Cited by 11
Cai, X., Tan, Z.-G., Li, J., Gao, W.-H., Li, S.-J., Li, J., Tang, Y. G., Li, H., & Hui, H. (2017) · Medical Science Monitor · doi:10.12659/msm.903252 · Cited by 11
Yanai, H., Adachi, H., Hakoshima, M., & Katsuyama, H. (2024) · Molecules · doi:10.3390/molecules29245936 · Cited by 11
Bioinformatics Analysis of MicroRNA Profiles Unveils Novel Biological Markers of Alzheimer’s Disease
Rahimpour, A., Heidarzadehpilehrood, R., Aghel, M., Jamalpoor, Z., Heydarian, P., Ghasemi, S. A., & Pirhoushiaran, M. (2022) · Neurochemical Journal · doi:10.1134/s1819712422030096 · Cited by 11
Yao, J., He, Z., You, G., Liu, Q., & Li, N. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45080402 · Cited by 9
Iketani, R., Ohno, K., Kawasaki, Y., Matsumoto, K., Yamada, H., & Kishino, S. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00929 · Cited by 10
Nguyen, H. D., Vu, G. H., & Kim, W. (2024) · Aspects of Molecular Medicine · doi:10.1016/j.amolm.2024.100047 · Cited by 9
Tortuous Paths of Insulin Signaling and Mitochondria in Alzheimer’s Disease
Carvalho, C., Cardoso, S., Correia, S. C., & Moreira, P. I. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-981-13-3540-2_9 · Cited by 10
Adams, M. S., Mensink, R. P., Plat, J., & Joris, P. J. (2024) · European Journal of Nutrition · doi:10.1007/s00394-024-03394-y · Cited by 10
Patel, B., Sheth, D. B., Vyas, A. J., Shah, S. R., Parmar, S. K., Patel, C. A., Patel, S. P., Beladiya, J., Pande, S. V., & Modi, K. (2022) · Metabolic Brain Disease · doi:10.1007/s11011-022-01056-8 · Cited by 9
RetractedInsulin and Insulin-Sensitizing Drugs in Neurodegeneration: Mitochondria as Therapeutic Targets
Cardoso, S., Santos, R. X., Correia, S. C., Carvalho, C., Zhu, X., Lee, H., Casadesús, G., Smith, M. A., Perry, G. L., & Moreira, P. I. (2009) · Pharmaceuticals · doi:10.3390/ph2030250 · Cited by 10
Altered plasma visfatin levels and insulin resistance in patients with Alzheimer’s disease
Sharifipour, E., Sharifimoghadam, S., Hassanzadeh, N., Mojarad, N. G., Ghoreishi, A., Hejazi, S. A., & Rohampour, K. (2019) · Acta Neurologica Belgica · doi:10.1007/s13760-019-01084-9 · Cited by 9
Беличенко, В. М., Bashirzade, A. A., Tenditnik, M. V., Dubrovina, N. I., Akopyan, A. A., Ovsyukova, M. V., Fedoseeva, L. A., Pupyshev, A. B., Aftanas, L. I., Amstislavskaya, T. G., et al. (2023) · Behavioural Brain Research · doi:10.1016/j.bbr.2023.114651 · Cited by 9
Multi-Target-Directed Ligand Approach in Anti-Alzheimer’s Drug Discovery
Patil, V. M., Masand, N., Gautam, V., Kaushik, S., & Wu, D. H. (2023) · Springer eBooks · doi:10.1007/978-981-99-2657-2_13 · Cited by 9
Hawkins, M. A. W., Keirns, N. G., Baraldi, A. N., Layman, H. M., Stout, M. E., Smith, C. E., Gunstad, J., Hildebrand, D. A., Vohs, K. D., & Lovallo, W. R. (2021) · Obesity Science & Practice · doi:10.1002/osp4.537 · Cited by 9
Heterogeneous effects of genetic risk for Alzheimer’s disease on the phenome
Wu, H. M., Goate, A., & O’Reilly, P. F. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01518-0 · Cited by 8
Sun, P., Hua, Q., & Schmitt, A. G. (2015) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026615666150813142611 · Cited by 8
Oxenkrug, G. F. (2015) · Molecular and integrative toxicology · doi:10.1007/978-3-319-15630-9_8 · Cited by 8
Sulindac Sulfide Induced Stimulation of Eryptosis
Zbidah, M., Lupescu, A., Yang, W., Bosc, A., Jilani, K., Shaik, N., & Lang, F. J. W. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000341483 · Cited by 7
Rabiee, N., Bagherzadeh, M., & Rabiee, M. (2018) · Current Diabetes Reviews · doi:10.2174/1573399814666181031154817 · Cited by 7
Direct Evidence for Glucose Consumption Acceleration by Carbonates in Cultured CellsPreprint
Sorimachi, K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/551259 · Cited by 7
The mTOR pathway: a common link between Alzheimer's disease and Down Syndrome
Wohlfert, A. J., Phares, J., & Granholm, A.-C. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13206183 · Cited by 6
Lee, J. Y., Kim, J., Shin, S. A., Park, S., Yoon, D. H., Kim, Y. K., Kim, Y. K., Moon, M. K., Koo, B. K., & Lee, J. (2018) · Journal of Clinical Medicine · doi:10.3390/jcm7110413 · Cited by 6
Effect of Long Term Consumption of High Calorie Diet and Calorie Restriction on Human Health
Farooqui, A. A. (2015) · Springer eBooks · doi:10.1007/978-3-319-15254-7_1 · Cited by 8
Ceramides Mediate Insulin-Induced Impairments in Cerebral Mitochondrial Bioenergetics in ApoE4 Mice
Carr, S. T., Saito, E. R., Walton, C. M., Saito, J. Y., Hanegan, C. M., Warren, C. E., Trumbull, A. M., & Bikman, B. T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242316635 · Cited by 5
Lewis, T. J., & Trempe, C. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812112-2.00007-0 · Cited by 8
Zhang, W., Liu, Y., Bao, H., Zhang, M., Gao, F., Kang, D., & Shen, Y. (2020) · Journal of Alzheimer s Disease · doi:10.3233/jad-200095 · Cited by 6
Xu, M. Q., Zhang, L., Li, P., Wang, C., & Shi, Y. (2020) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2020.04.002 · Cited by 7
Karczewska‐Kupczewska, M., Nikołajuk, A., Filarski, R., Majewski, R., & Tarasów, E. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-00107 · Cited by 6
Bowirrat, A., Yassin, M., Abir, M., Bisharat, B., & Armaly, Z. (2012) · InTech eBooks · doi:10.5772/48558 · Cited by 6
Personalized, Precision Medicine to Cure Alzheimer’s Dementia: Approach #1
Fessel, J. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25073909 · Cited by 5
Vincenzo, M. D., Pellegrino, P., Schiappa, G., Campanati, A., Vescovo, V. D., Piccirillo, S., Ambrogini, P., Arnaldi, G., & Orciani, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26031357 · Cited by 5
Plasma Leptin Reflects Progression of Neurofibrillary Pathology in Animal Model of Tauopathy
Cente, M., Zórad, Š., Smolek, T., Fialová, Ľ., Ivanovova, N. P., Kršková, K., Balážová, L., Škrabana, R., & Filipčík, P. (2020) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-020-00972-6 · Cited by 5
Alzheimer’s Disease and Diabetes
Brent, D. A., Gary, L., Aboud, Z., & Gordon, W. (2013) · InTech eBooks · doi:10.5772/54913 · Cited by 6
La resistencia a la insulina como mecanismo de adaptación durante la evolución humana
Ricart, W., & Fernández‐Real, J. M. (2010) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2010.05.003 · Cited by 5
da Costa, A. V., Calábria, L. K., Santos, P. D. S., Goulart, L. R., & Espíndola, F. S. (2014) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.03.020 · Cited by 4
Lee, T. H.-Y., Hurwitz, E. L., Cooney, R. V., Wu, Y. Y., Wang, C., Masaki, K., & Grandinetti, A. (2019) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2019.06.031 · Cited by 6
In Silico Analysis to Link Insulin Resistance, Obesity and Ageing with Alzheimer’s Disease
Sarkar, P. A., Jayaraj, P., Patwardhan, K., Yeole, S., Das, S., Somaiya, Y., Desikan, R., & Thirumurugan, K. (2021) · Journal of Molecular Neuroscience · doi:10.1007/s12031-021-01875-x · Cited by 5
Deletion of serine racemase reverses neuronal insulin signaling inhibition by amyloid‐β oligomers
Zhou, J., Zhang, Z., yang, Y., Liao, F., Zhou, P., Wang, Y., Zhang, H., Jiang, H., Alinejad, T., Shan, G., et al. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15664 · Cited by 5
de la Monte, S., Tong, M., & Jack, R. (2011) · InTech eBooks · doi:10.5772/17682 · Cited by 5
Mu, N., Xu, S., Chang, Q., Rao, D. P., Chen, J., & Ma, C. (2013) · PubMed · Cited by 5
Ibrahim, O. M., & Hassan, M. A. (2018) · Pharmacology & Pharmacy · doi:10.4236/pp.2018.96013 · Cited by 4
Zhang, H., Mo, L., Chen, X., Li, M., Li, M., Xu, Y., Zeng, M., He, Z., Shen, Q. W., Chen, J., et al. (2023) · Food Science and Human Wellness · doi:10.26599/fshw.2022.9250240 · Cited by 4
Type 2 Diabetes and Mild Cognitive Impairment*
Qu, M., Fang, C., Zhang, X., Zhao, C.-Z., Mao, S., & Gao, Z. (2012) · PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS · doi:10.3724/sp.j.1206.2012.00352 · Cited by 4
Age-Related Changes in the Phospholipase D-Dependent Signal Pathway of Insulin in the Rat Neocortex
Babenko, N. A., & Kharchenko, V. S. (2013) · Neurophysiology · doi:10.1007/s11062-013-9346-9 · Cited by 4
Babenko, N. A., & Kharchenko, V. S. (2015) · Neurophysiology · doi:10.1007/s11062-015-9491-4 · Cited by 4
Cognitive Impairment and the Diabetic Brain
Jellinger, K. A. (2015) · International Journal of Neurology and Neurotherapy · doi:10.23937/2378-3001/2/2/1033 · Cited by 4
Practical considerations for managing patients with diabetes and dementia
Mair, M. L., Athavale, R., & Abdelhafiz, A. H. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1395692 · Cited by 4
Metadata
- Authors
- De La Monte, S. M.
- Venue
- BMB Reports
- Published
- 2009-08-31
- Volume
- 42
- Issue
- 8
- Pages
- 475-481
- ISSN
- 1976-6696 (ISSN-L)
- PMC
- PMC4600067
- OpenAlex
- W1963640549
- Cited by
- 392
- References
- 57
- Citations by year
- 2026: 7 · 2025: 11 · 2024: 17 · 2023: 23 · 2022: 29 · 2021: 22 · 2020: 22 · 2019: 21 · 2018: 20 · 2017: 24 · 2016: 25 · 2015: 36 · 2014: 24 · 2013: 23 · 2012: 39
- FWCI
- 3.22
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by-nc
- Locations
- BMB Reports (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health (5r01aa011431-26)
- National Institute on Alcohol Abuse and Alcoholism (R01-AA011431, AA-12908, K24AA016126, AA-16126, AA11431, R56AA011431, R01AA012908, R37AA011431)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- brain insulin resistance, Alzheimer's disease, insulin-like growth factor, cognitive impairment, neurodegeneration, type 2 diabetes, obesity, liver-brain axis, ceramide, blood-brain barrier, oxidative stress, neuroinflammation, neuronal cell death, insulin signaling
- MeSH terms
- Alzheimer Disease, Animals, Brain, Humans, Insulin Resistance, Models, Biological, Somatomedins, Amyloid beta-Protein Precursor
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
